RS2227631 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:Plasminogen activator inhibitor type 1 levels (PAI-1)]"
GWAS Studies (12)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| PDGFA/SERPINE1 protein level ratio | — | OR: 0.18 | 3E-148 | PubMed |
| DKK1/SERPINE1 protein level ratio | — | OR: 0.15 | 2E-108 | PubMed |
| SERPINE1/SPARC protein level ratio | — | OR: 0.15 | 6E-105 | PubMed |
| ANGPT1/SERPINE1 protein level ratio | — | OR: 0.13 | 2E-81 | PubMed |
| CD40LG/SERPINE1 protein level ratio | — | OR: 0.12 | 2E-66 | PubMed |
| LAT/SERPINE1 protein level ratio | — | OR: 0.1 | 2E-50 | PubMed |
| Plasminogen activator inhibitor type 1 levels (PAI-1) | — | β: 0.073 | 3E-24 | PubMed |
| Plasminogen activator inhibitor 1 levels | A | OR: 0.1 | 6E-15 | PubMed |
| Ischemic stroke or plasminogen activator inhibitor 1 levels (pleiotropy) | — | — | 2E-14 | PubMed |
| Fibrinogen levels or plasminogen activator inhibitor 1 levels (pleiotropy) | — | — | 2E-14 | PubMed |
| Venous thromboembolism or plasminogen activator inhibitor 1 levels (pleiotropy) | — | — | 5E-14 | PubMed |
| Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | — | — | 1E-13 | PubMed |